Cargando…
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
AIMS: Familial hypertrophic cardiomyopathy (HCM) is one the most common heart disorders, with gene mutations in the cardiac sarcomere. Studying HCM with patient-specific induced pluripotent stem-cell (iPSC)-derived cardiomyocytes (CMs) would benefit the understanding of HCM mechanism, as well as the...
Autores principales: | Han, Lu, Li, Yang, Tchao, Jason, Kaplan, Aaron D., Lin, Bo, Li, You, Mich-Basso, Jocelyn, Lis, Agnieszka, Hassan, Narmeen, London, Barry, Bett, Glenna C.L., Tobita, Kimimasa, Rasmusson, Randall L., Yang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217687/ https://www.ncbi.nlm.nih.gov/pubmed/25209314 http://dx.doi.org/10.1093/cvr/cvu205 |
Ejemplares similares
-
Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy
por: Lin, Bo, et al.
Publicado: (2015) -
Engineered Human Muscle Tissue from Skeletal Muscle Derived Stem Cells and Induced Pluripotent Stem Cell Derived Cardiac Cells
por: Tchao, Jason, et al.
Publicado: (2013) -
Markov Models of Use-Dependence and Reverse Use-Dependence during the Mouse Cardiac Action Potential
por: Zhou, Qinlian, et al.
Publicado: (2012) -
Combined biophysical and soluble factor modulation induces cardiomyocyte differentiation from human muscle derived stem cells
por: Tchao, Jason, et al.
Publicado: (2014) -
Genomic upregulation of cardiac Cav1.2α and NCX1 by estrogen in women
por: Papp, Rita, et al.
Publicado: (2017)